Assignee
CELL GENESYS INC
US·81 granted patents·25 pending applications·6,726 citations·filing 1992–2009
Top patents by PatentIndex Score
106 records- 0198US6428953B1Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2000·Granted Aug 6, 2002·125 cites·9 claims
- 0298US5994136AMethod and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 1997·Granted Nov 30, 1999·743 cites·16 claims
- 0398US5413923AHomologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1992·Granted May 9, 1995·648 cites·12 claims
- 0498US5359046AChimeric chains for receptor-associated signal transduction pathwaysCELL GENESYS INC·Filed 1992·Granted Oct 25, 1994·729 cites·21 claims
- 0597US6319494B1Chimeric chains for receptor-associated signal transduction pathwaysCELL GENESYS INC·Filed 1995·Granted Nov 20, 2001·348 cites·2 claims
- 0697US5686281AChimeric receptor molecules for delivery of co-stimulatory signalsCELL GENESYS INC·Filed 1995·Granted Nov 11, 1997·362 cites·11 claims
- 0796US7179903B2Liver specific transcriptional enhancerCELL GENESYS INC·Filed 2004·Granted Feb 20, 2007·89 cites·9 claims
- 0896US7083981B2Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2005·Granted Aug 1, 2006·26 cites·14 claims
- 0996US6692736B2Cell-specific adenovirus vectors comprising an internal ribosome entry siteCELL GENESYS INC·Filed 2001·Granted Feb 17, 2004·129 cites·41 claims
- 1096US6436394B1Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereofCELL GENESYS INC·Filed 2000·Granted Aug 20, 2002·90 cites·26 claims
- 1196US6165782AMethod and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 1999·Granted Dec 26, 2000·182 cites·9 claims
- 1296US5712149AChimeric receptor molecules for delivery of co-stimulatory signalsCELL GENESYS INC·Filed 1995·Granted Jan 27, 1998·176 cites·25 claims
- 1395US6808905B2Lentiviral vectors encoding clotting factors for gene therapyCELL GENESYS INC·Filed 2002·Granted Oct 26, 2004·64 cites·33 claims
- 1495US6103521AMultispecific chimeric receptorsCELL GENESYS INC·Filed 1995·Granted Aug 15, 2000·209 cites·47 claims
- 1595US5686279AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1994·Granted Nov 11, 1997·151 cites·18 claims
- 1694US7498024B2Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage siteCELL GENESYS INC·Filed 2004·Granted Mar 3, 2009·32 cites·28 claims
- 1793US7473418B2Pan cancer oncolytic vectors and methods of use thereofCELL GENESYS INC·Filed 2005·Granted Jan 6, 2009·31 cites·10 claims
- 1893US7048920B2Recombinant oncolytic adenovirus for human melanomaCELL GENESYS INC·Filed 2002·Granted May 23, 2006·54 cites·19 claims
- 1993US5872005APackaging cell lines for adeno-associated viral vectorsCELL GENESYS INC·Filed 1995·Granted Feb 16, 1999·143 cites·15 claims
- 2093US5858740AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1995·Granted Jan 12, 1999·91 cites·50 claims
- 2193US5589369ACells homozygous for disrupted target lociCELL GENESYS INC·Filed 1994·Granted Dec 31, 1996·455 cites·11 claims
- 2292US7485291B2Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereofCELL GENESYS INC·Filed 2003·Granted Feb 3, 2009·33 cites·20 claims
- 2392US6916918B2Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 12, 2005·32 cites·14 claims
- 2492US6911200B2Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiationCELL GENESYS INC·Filed 2001·Granted Jun 28, 2005·30 cites·9 claims
- 2592US6585968B2Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereofCELL GENESYS INC·Filed 2001·Granted Jul 1, 2003·36 cites·22 claims
- 2692US6506604B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2001·Granted Jan 14, 2003·32 cites·22 claims
- 2792US5834256AMethod for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 1993·Granted Nov 10, 1998·104 cites·99 claims
- 2891US7250299B1Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2000·Granted Jul 31, 2007·31 cites·18 claims
- 2991US6936243B2Adeno-associated viral vector-mediated delivery of DNA to cells of the liverCELL GENESYS INC·Filed 2000·Granted Aug 30, 2005·36 cites·5 claims
- 3091US6514752B1Homologous recombination for universal donor cells and chimeric mammalian hostsCELL GENESYS INC·Filed 1995·Granted Feb 4, 2003·60 cites·14 claims
- 3190US6676935B2Tissue specific adenoviral vectorsCELL GENESYS INC·Filed 1998·Granted Jan 13, 2004·102 cites·31 claims
- 3290US6548286B1Methods for increasing the efficiency of recombinant AAV productCELL GENESYS INC·Filed 1998·Granted Apr 15, 2003·94 cites·14 claims
- 3390US6139835AHomologous recombination for allogeneic donor cellsCELL GENESYS INC·Filed 1995·Granted Oct 31, 2000·54 cites·62 claims
- 3489US7575919B2Adenovirus vectors containing cell status-specific response elements and methods of use thereofCELL GENESYS INC·Filed 2004·Granted Aug 18, 2009·11 cites·9 claims
- 3589US7186699B2Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genesCELL GENESYS INC·Filed 2004·Granted Mar 6, 2007·52 cites·15 claims
- 3689US6991935B2Target cell-specific adenoviral vectors containing E3 and methods of use thereofCELL GENESYS INC·Filed 2002·Granted Jan 31, 2006·16 cites·19 claims
- 3788US7364727B2Metastatic colon cancer specific promoter and uses thereofCELL GENESYS INC·Filed 2003·Granted Apr 29, 2008·19 cites·12 claims
- 3888US5741899AChimeric receptors comprising janus kinase for regulating cellular pro liferationCELL GENESYS INC·Filed 1995·Granted Apr 21, 1998·80 cites·12 claims
- 3988US5578461AGene manipulation and expression using genomic elementsCELL GENESYS INC·Filed 1993·Granted Nov 26, 1996·121 cites·10 claims
- 4087US7132284B2Adenovirus packaging cell linesCELL GENESYS INC·Filed 2005·Granted Nov 7, 2006·7 cites·23 claims
- 4187US7074618B2Adenoviral E1A/E1B complementing cell lineCELL GENESYS INC·Filed 2004·Granted Jul 11, 2006·14 cites·10 claims
- 4287US7026164B2Adenovirus packaging cell linesCELL GENESYS INC·Filed 2003·Granted Apr 11, 2006·14 cites·11 claims
- 4387US6852528B2Human and mouse uroplakin II gene transcriptional regulatory elementsCELL GENESYS INC·Filed 2001·Granted Feb 8, 2005·26 cites·27 claims
- 4486US7252991B2Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cellsCELL GENESYS INC·Filed 2002·Granted Aug 7, 2007·11 cites·1 claims
- 4586US7217421B1Cancer-associated antigens and methods of their identification and useCELL GENESYS INC·Filed 2000·Granted May 15, 2007·25 cites·9 claims
- 4686US6924144B2Method and means for producing high titer, safe, recombinant lentivirus vectorsCELL GENESYS INC·Filed 2002·Granted Aug 2, 2005·8 cites·17 claims
- 4786US6407221B1Chimeric chains for receptor-associated signal transduction pathwaysCELL GENESYS INC·Filed 1995·Granted Jun 18, 2002·65 cites·10 claims
- 4885US7001764B2Compositions comprising tissue specific adenoviral vectorsCELL GENESYS INC·Filed 2002·Granted Feb 21, 2006·14 cites·21 claims
- 4984US7276233B2Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapyCELL GENESYS INC·Filed 2005·Granted Oct 2, 2007·2 cites·4 claims
- 5084US7109029B2Vector constructsCELL GENESYS INC·Filed 2002·Granted Sep 19, 2006·29 cites·27 claims
Showing the top 50 of 106 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CELL GENESYS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →